Myriad Genetics Stock Price (NASDAQ:MYGN)

Add to My Stocks
$18.98 $0.07 (0.37%) MYGN stock closing price Feb 24, 2017 (Closing)
Myriad Genetics
24 FEB 2017
amigobulls logo
MYGN hand_up
MYGN vs S&P 500
Closing Price: Feb 24, 2017
$18.98 ( -0.37%)
S&P 500
2367.3 ( 0.15%)
52 Week Price Range
1 Year Return: -46.08%
Q2 Growth*
Profitable ?
net image
2017 Q2 Net Profit
PE Valuation
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Myriad Genetics Snapshot Video

12 5 2

MYGN Stock Details

Prev Close* : $19.05
Market Cap:
Day Low: $18.56
52 Week Low: $15.15
Open: $18.99
Volume: 1666711
Day High: $19.14
52 Week High: $39.74

Latest Stock Market News

Latest Articles

Myriad Genetics News - From Partners

MYGN Stockcharts

View MYGN PE ratio, PS ratio stocks charts and compare with peers.
MYGN Chart
Note: Compare Myriad Genetics stock price history with the index and industry peers.

Myriad Genetics Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Myriad Genetics Returns

(return on equity)

Myriad Genetics Financial Ratios

Asset Turnover
Receivables Turnover

MYGN Industry Peers

Company Price Change (%)
Alder Biopharma (ALDR)21.780.12 (0.55%)
Axovant Sciences (AXON)11.720.12 (1.01%)
Foundation Medicine (FMI)23.10.15 (0.65%)
Oncocyte (OCX)5.150.17 (3.41%)
Genomic Health (GHDX)29.830.3 (1.02%)
Interleukin Genetics (ILIU)0.120.01 (9.09%)
Fulgent Genetic (FLGT)11.230.05 (0.45%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Incyte (INCY)131.219.26 (7.59%)
Sarepta Therapeutics (SRPT)32.021.87 (6.2%)
Stemline Therapeutics (STML)6.850.4 (6.2%)
Bluebird Bio (BLUE)823.7 (4.73%)
Puma Biotech (PBYI)36.21.5 (4.32%)
Sangamo BioSciences (SGMO)40.15 (3.9%)
Epizyme (EPZM)12.150.45 (3.85%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017
CompanyPriceChange (%)
Achillion Pharma (ACHN)3.860.38 (8.96%)
Chromadex (CDXC)2.740.13 (4.53%)
Idera Pharma (IDRA)1.670.06 (3.47%)
Inovio Pharma (INO)6.680.22 (3.19%)
VIVUS (VVUS)1.140.03 (2.56%)
Ligand Pharma (LGND)100.382.46 (2.39%)
Compugen (CGEN)4.30.1 (2.27%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017

Myriad Genetics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues753.8M723.1M778.21M613.16M496M
Net Income125.3M80.2M176.22M147.13M112.15M
Total Operating Expense429.7M441.5M394.56M305.53M251.02M
view Myriad Genetics, Inc. income statement
balance sheet20162015201420132012
Total Assets880.5M766.2M823.81M803.82M690.63M
Total Liabilities132.4M104.1M104.81M75.22M54.97M
Shareholders Equity748.1M662.1M718.99M728.59M635.66M
view Myriad Genetics, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-65.4M-40.7M-59.97M-41.02M-28.76M
Net Cash From (Used By) Operating Activities166.3M140.5M190.21M173.86M141.84M
Increase (Decrease) In Prop Plant And Equipment-5M-23.9M-14.27M-11.37M-9.4M
view Myriad Genetics, Inc. cashflow statement

Myriad Genetics, Inc. Stock News - Partner Headlines

Myriad Genetics Stock Message Board

Myriad Genetics stock lost -0.37 %, and the last close price as of 24 Feb, 2017 is 18.98 for MYGN stock. Looking at Myriad Genetics market capitalization, which currently stands at 1.3B, we can say that MYGN stock is a Small cap stock. A value investor must look at the fundamentals of a stock, and perform Myriad Genetics valuation, even though in the short-term sentiment and current breaking news might affect Myriad Genetics stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy MYGN stock than sell it, then Myriad Genetics stock price goes up. Conversely, if more investors wanted to sell MYGN stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 1666711 on the last trading day, as is evident from Myriad Genetics stock chart, and MYGN stock quote data. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Myriad Genetics does not pay dividends. Myriad Genetics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.